Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer? A randomized controlled trial, Journal of Hepato-Biliary-Pancreatic Sciences, February 2016, Wiley,
DOI: 10.1002/jhbp.318.
You can read the full text:
Contributors
The following have contributed to this page